Intended for healthcare professionals

Practice Uncertainties

Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h569 (Published 04 March 2015) Cite this as: BMJ 2015;350:h569

Cited by...

Quetiapine use in adults in the community: a population-based study in Alberta, Canada
- Abstract
- Fulltext
- PDF
Severe adverse reactions associated with quetiapine
- Abstract
- Fulltext
- PDF

See other articles in issue 7998

Article tools

PDF 3 responses

Respond to this article
Print
Alerts & updates
Article alerts
Please note: your email address is provided to the journal, which may use this information for marketing purposes.

Log in or register:

Username *

Password *

Register for alerts

If you have registered for alerts, you should use your registered email address as your username
Citation tools
Download this article to citation manager

Tamara Pringsheim assistant professor, David Gardner professor, Scott B Patten professor

Pringsheim T, Gardner D, Patten S B. Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks? BMJ 2015; 350 :h569 doi:10.1136/bmj.h569

BibTeX (win & mac)Download

EndNote (tagged)Download

EndNote 8 (xml)Download

RefWorks Tagged (win & mac)Download

RIS (win only)Download

MedlarsDownload

Help

If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

EndNote

ProCite

Reference Manager

RefWorks

Zotero
Request permissions

Topics

more
less